Stephen Willard - Jul 12, 2022 Form 3 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Chief Executive Officer, Director
Signature
/s/ Stephen Willard
Stock symbol
NRXP
Transactions as of
Jul 12, 2022
Transactions value $
$0
Form type
3
Date filed
7/22/2022, 04:27 PM
Next filing
Dec 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NRXP Restricted Common Stock, par value $0.001 per share 1M Jul 12, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of an inducement award of 1,000,000 restricted shares of the Company's common stock. The restricted shares will vest in approximately equal installments over three (3) years from July 12, 2022, subject generally to the reporting person's continued service to the Company through the applicable vesting date.